Pyridine-derivatives

HPLC of Formula: C8H10ClNO3. Recently I am researching about CORONARY-HEART-DISEASE; BETA-CELL TURNOVER; ADIPOSE-TISSUE; COFFEE CONSUMPTION; PLASMA; RISK; ASSOCIATION; BIOMARKERS; CANCER; PHOSPHOLIPIDS, Saw an article supported by the United Kingdom Medical Research Council Epidemiology Unit core grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12015/5, MC_UU_12015/1]; National Institute for Health Research (NIHR) Biomedical Research Centre CambridgeNational Institute for Health Research (NIHR) [IS-BRC-1215-20014]; Dutch Scientific Organization (ZonMW)Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development; Foundation Plan Alzheimer; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USA [3T32DK007703, T32CA009001, UM1 CA167552, R01 HL35464, AA11181, HL35464, CA55075, HL60712, P30 DK46200, M01-RR-43, CA186107, CA87969, CA49449, HL34594, CA167552, HL088521]; Netherlands Heart FoundationNetherlands Heart Foundation [2000T401]; NIH (NIH/National Heart, Lung, and Blood Institute [NHLBI]); NIH (ODS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) – USA [R01HL-076200]; Unilever RD, Vlaardingen; United States National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) – USA [N01-AG012100]; National Institute of Aging (NIA) Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Michael Smith Foundation for Medical ResearchMichael Smith Foundation for Health Research [17644]; Canadian Cancer SocietyCanadian Cancer Society (CCS) [704735]; Ministry of Science and Technology; National Taiwan University, TaiwanNational Taiwan University [MOST 103-2314-B-002 -135-MY3, NSC 100-2314-B-002 -113 -MY3, NTUH 105-S3120, NTUH 106-S3453]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Institute on Aging (NIA) [R01AG023629]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Heart Lung & Blood Institute (NHLBI); Boston University [N01-HC25195]; EU FP6 programmeEuropean Commission [LSHM_CT_2006_037197]; Academy of FinlandAcademy of FinlandEuropean Commission; VicHealth; Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)Cancer Council Victoria; Australia’s National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [209057, 126403]; NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Center for Research Resources (NCRR) [UL1-TR000040, UL1-TR-001079]; European UnionEuropean Commission; Juselius Foundation; Uppsala University Hospital; Swedish Research Council for Health, Working Life and WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte); Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission [COGINUT ANR-06-PNRA-005]; Fondation Plan Alzheimer [FCS 2009-2012]; Uppsala City Council; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Diabetes Foundation (UR); NHLBI, NIH, U.S. Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C]; Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux d’Aquitaine et BourgogneRegion Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine; Fondation de FranceFondation de France; Ministry of Research-Institut National de la Sante; Caisse Nationale pour la Solidarite et l’Autonomie; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Heart Lung & Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, R01-HL-085710, U01HL080295, U01HL130114, U01-HL-47892, U01-HL-47902, N01-HC-95161, N01-HC-95162, N01-HC95163, N01-HC-95164, N01-HC-95165, N01-HC95166, N01-HC-95167, N01-HC-95168, N01HC-95169]; [DK-29867]; [R01-58329]; [DK-079888]; [HHSN268201500003I]; [N01-HC-95159]; [N01-HC95160]. Published in PUBLIC LIBRARY SCIENCE in SAN FRANCISCO ,Authors: Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG. The CAS is 65-22-5. Through research, I have a further understanding and discovery of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. Conclusions Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. HPLC of Formula: C8H10ClNO3. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

An article A Photoredox Coupling Reaction of Benzylboronic Esters and Carbonyl Compounds in Batch and Flow WOS:000480371600076 published article about ALDEHYDES; ACIDS; BENZYLATION; KETONES in [Chen, Yiding; May, Oliver; Ley, Steven, V] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Blakemore, David C.] Pfizer Inc, Med Design, Eastern Point Rd, Groton, CT 06340 USA in 2019.0, Cited 44.0. COA of Formula: C12H9NO. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1

Mild cross-coupling reaction between benzylboronic esters with carbonyl compounds and some imines was achieved under visible-light-induced iridium-catalyzed photoredox conditions. Functional group tolerance was demonstrated by 51 examples, including 13 heterocyclic compounds. Gram-scale reaction was realized through the use of computer-controlled continuous flow photoreactors.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Chen, YD; May, O; Blakemore, DC; Ley, SV or concate me.. COA of Formula: C12H9NO

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Computed Properties of C12H9NO. Recently I am researching about AGGREGATION-INDUCED EMISSION; POLYMERIC NANOPARTICLES; ORGANIC NANOPARTICLES; LIQUID-CHROMATOGRAPHY; HYDROGEN-SULFIDE; CLICK REACTION; HUMAN PLASMA; AIE; HOMOCYSTEINE; THIOLS, Saw an article supported by the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31471693]; Jiangsu Provincial Policy Guidance Plan (university-industry-research cooperation) prospective joint research projects [BY2016005-07]; Jiangsu Agricultural Science and Technology Innovation Fund [CX(17)3052]. Published in ELSEVIER SCI LTD in OXFORD ,Authors: Sheng, HC; Hu, YH; Zhou, Y; Fan, SM; Cao, Y; Zhao, XX; Yang, WG. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

A new imidazo [1,5-alpha]pyridine-based fluorescent probe, named MZC-AC, is developed for the detection of cysteine (Cys) based on an excited state intramolecular proton transfer (ESIPT) mechanism. The probe MZC-AC uses an acrylate moiety as the ESIPT blocking group as well as the recognition site. Upon the treatment with Cys, MZC-AC exhibits a dramatic fluorescence enhancement (85-fold) and a large Stokes shift (166 nm). The limit of detection obtained from fluorescent titration was as low as 0.07 mu M. MZC-AC displays highly sensitive and selective response to Cys over homocysteine (Hcy) and glutathione (GSH). Significantly, MZC-AC could be used to detect Cys in living cells.

Computed Properties of C12H9NO. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Sheng, HC; Hu, YH; Zhou, Y; Fan, SM; Cao, Y; Zhao, XX; Yang, WG or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recently I am researching about LEWIS-ACID; TRANSFER HYDROGENATION; ALLYLIC AMINATION; BOND-ACTIVATION; COMPLEXES; REACTIVITY; PLATINUM; H-2; COCATALYST; CONVERSION, Saw an article supported by the NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); FQRNTFQRNT. Published in ROYAL SOC CHEMISTRY in CAMBRIDGE ,Authors: Lorenzini, F; Lagueux-Tremblay, PL; Kayser, LV; Anderson, E; Arndtsen, BA. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone. HPLC of Formula: C12H9NO

We describe here the synthesis and structural characterization of two new classes of ambiphilic, N-boryl imine ligands, wherein boron is associated with a Lewis basic imine nitrogen. These ligands can be easily generated in two steps from the corresponding pyridinyl- and phosphinyl-tethered aldehydes. B-11 NMR analysis suggests the association of the Lewis acidic boron to either the pyridine unit or via intermolecular acid/base interactions with the imine. Both of these ligands can coordinate to palladium, and their structures were confirmed by X-ray crystallography.

HPLC of Formula: C12H9NO. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Lorenzini, F; Lagueux-Tremblay, PL; Kayser, LV; Anderson, E; Arndtsen, BA or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Computed Properties of C8H9NO2. Authors Du, JY; Li, YM; Xu, JC; Huang, MQ; Wang, J; Chao, JF; Wu, JH; Sun, HB; Ding, HM; Ye, H in ELSEVIER SCI LTD published article about in [Du, Jingyi; Huang, Mingquan; Wang, Juan; Wu, Jihong; Ye, Hong] Beijing Technol & Business Univ BTBU, China Light Ind, Key Lab Brewing Mol Engn, Beijing 100048, Peoples R China; [Li, Yueming; Xu, Jianchun; Chao, Jinfu; Sun, Huibin; Ding, Haimei] Qingdao Langyatai Grp Ltd, Qingdao 266500, Peoples R China in 2021, Cited 44. The Name is Ethyl nicotinate. Through research, I have a further understanding and discovery of 614-18-6

A study was carried out to determine systematically the key aroma-active compounds of Langyatai Baijiu with Jian flavour (LBJF) using sensory omics analysis (SOA). A total of 56 odorants were screened out using gas chromatography-olfactometry-mass spectrometry (GC-O-MS)/Osme analysis. Among them, 15 aroma-active components were first identified. After quantitation, 30 odorants had odour activity values (OAVs) > 1.0 in LBJF. Recombinant and omission experiments proved that the esters, alcohols, acids, especially ethyl hexanoate, gamma psi psi-nonalactone, and dimethyl trisulfide, were critical to the flavour of LBJF. The basic and commercial liquors had obvious differences in the skeleton compositions of esters and acids. This study uncovers the characteristics of Jian flavour Baijiu (JFB) and provides a scientific basis for the quality control of JFB, which is helpful for the development of Chinese Baijiu flavour styles.

About Ethyl nicotinate, If you have any questions, you can contact Du, JY; Li, YM; Xu, JC; Huang, MQ; Wang, J; Chao, JF; Wu, JH; Sun, HB; Ding, HM; Ye, H or concate me.. Computed Properties of C8H9NO2

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recommanded Product: Ethyl nicotinate. Authors Liu, JJ; Chen, JY; Li, SS; Tian, WN; Wu, HG; Han, BZ in TAYLOR & FRANCIS INC published article about in [Liu, Jingjing; Li, Shuangshi; Tian, Weina] Beijing Polytech, Sch Bioengn, Dept Food Technol, Beijing, Peoples R China; [Chen, Jingyu; Han, Beizhong] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Lab Food Qual & Safety, Beijing, Peoples R China; [Wu, Haigang] Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China in 2021, Cited 32. The Name is Ethyl nicotinate. Through research, I have a further understanding and discovery of 614-18-6

Sufu is a pleasant-tasting, traditional Chinese fermented soybean food that is rich in nutrients. In this study, the changes of volatile and nonvolatile metabolites in sufu fermented by bacillus licheniformis, were investigated. The results indicated that a total of 55 kinds of nonvolatile compounds were detected, including 2 carbohydrates, 4 alcohols, 17 amino acids, 18 organic acids, 6 biogenic amines, and 8 other substances. Furthermore, a total of 58 volatile compounds identified were composed of 11 esters, 16 alcohols, 10 acids, and 21 miscellaneous compounds. Inoculation of bacillus licheniformis enriched the metabolite pro?le of sufu and improved its functionality and safety of edibility. It was observed that the pure fermented starter resulted in controlled acceleration of sufu maturation.

Recommanded Product: Ethyl nicotinate. About Ethyl nicotinate, If you have any questions, you can contact Liu, JJ; Chen, JY; Li, SS; Tian, WN; Wu, HG; Han, BZ or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

I found the field of Oncology; Pharmacology & Pharmacy very interesting. Saw the article Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis published in 2020.0. Quality Control of Phenyl(pyridin-2-yl)methanone, Reprint Addresses Jin, JF (corresponding author), Guilin Med Univ, Affiliated Hosp, Lab Hepatobiliary & Pancreat Surg, Guilin 541001, Guangxi, Peoples R China.; Huang, ZQ (corresponding author), Guilin Med Univ, Dept Pathol, Affiliated Hosp, 15 Lequn Rd, Guilin 541001, Guangxi, Peoples R China.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

Objective: To overcome the disadvantages of cisplatin, numerous platinum (Pt) complexes have been prepared. However, the anticancer activity and mechanism of Pt(II) complexed with 2-benzoylpyridine [Pt(II)-Bpy]: [PtCl2(DMSO)L] (DMSO = dimethyl sulfoxide, L = 2-benzoylpyridine) in cancer cells remain unknown. Methods: Pt(II)-Bpy was synthesized and characterized by spectrum analysis. Its anticancer activity and underlying mechanisms were demonstrated at the cellular, molecular, and in vivo levels. Results: Pt(II)-Bpy inhibited tumor cell growth, especially HepG2 human liver cancer cells, with a half-maximal inhibitory concentration of 9.8 +/- 0.5 mu M, but with low toxicity in HL-7702 normal liver cells. Pt(H)Bpy induced DNA damage, which was demonstrated through a marked increase in the expression of cleaved-poly (ADP ribose) polymerase (PARP) and gamma-H2A histone family member X and a decrease in PARP expression. The interaction of Pt(II)-Bpy with DNA at the molecular level was most likely through an intercalation mechanism, which might be evidence of DNA damage. Pt(II)-Bpy initiated cell cycle arrest at the S phase in HepG2 cells. It also caused severe loss of the mitochondria( membrane potential; a decrease in the expression of caspase-9 and caspase-3; an increase in reactive oxygen species levels; the release of cytochrome c and apoptotic protease activation factor; and the activation of caspase-9 and caspase-3 in HepG2 cells, which in turn resulted in apoptosis. Meanwhile, changes in p53 and related proteins were observed including the upregulation of p53, the phosphorylation of p53, p21, B-cell lymphoma-2-associated X protein, and NOXA; and the down-regulation of B-cell lymphoma 2. Moreover, Pt(II)-Bpy displayed marked inhibitory effects on tumor growth in the HepG2 nude mouse model. Conclusion: Pt(II)-Bpy is a potential candidate for cancer chemotherapy.

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Li, YL; Gan, XL; Zhu, RP; Wang, XH; Liao, DF; Jin, JF; Huang, ZQ or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Safety of Phenyl(pyridin-2-yl)methanone. In 2019.0 ACTA CRYSTALLOGR C published article about SUPEROXIDE-DISMUTASE ACTIVITY; DOT-N INTERACTIONS; COPPER(II) COMPLEXES; CRYSTAL-STRUCTURE in [Araujo, Vinicius Oliveira; Schwade, Vania Denise] Fundacao Univ Fed Grande Dourados, Fac Ciencias Exatas & Tecnol, Rodovia Dourados Itahum,Km 12, BR-79804970 Dourados, MS, Brazil; [Tirloni, Brbara] Univ Fed Santa Maria, Dept Quim, Ave Roraima 1000, BR-97105900 Santa Maria, RS, Brazil; [Streit, Livia] Univ North Georgia, Dept Chem & Biochem, 3820 Mundy Mill Rd, Oakwood, GA 30566 USA in 2019.0, Cited 22.0. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1.

Semicarbazones can exist in two tautomeric forms. In the solid state, they are found in the keto form. This work presents the synthesis, structures and spectroscopic characterization (IR and NMR spectroscopy) of four such compounds, namely the neutral molecule 4-phenyl-1-[phenyl(pyridin-2-yl)methylidene] semicarbazide, C19H16N4O, (I), abbreviated as HBzPyS, and three different hydrated salts, namely the chloride dihydrate, C19H17N4O+center dot Cl-center dot 2H(2)O, (II), the nitrate dihydrate, C19H17N4O+center dot NO3-center dot 2H(2)O, (III), and the thiocyanate 2.5-hydrate, C19H17N4O+center dot SCN-center dot 2.5H(2)O, (IV), of 2-[phenyl({[(phenylcarbamoyl) amino]imino})methyl]pyridinium, abbreviated as [H(2)BzPyS](+)center dot X-center dot nH(2)O, with X = Cl- and n = 2 for (II), X= NO3- and n = 2 for (III), and X = SCN- and n = 2.5 for (IV), showing the influence of the anionic form in the intermolecular interactions. Water molecules and counter-ions (chloride or nitrate) are involved in the formation of a two-dimensional arrangement by the establishment of hydrogen bonds with the N-H groups of the cation, stabilizing the E isomers in the solid state. The neutral HBzPyS molecule crystallized as the E isomer due to the existence of weak pi-pi interactions between pairs of molecules. The calculated IR spectrum of the hydrated [H(2)BzPyS](+) cation is in good agreement with the experimental results.

Safety of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Araujo, VO; Tirloni, B; Streit, L; Schwade, VD or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Quality Control of Phenyl(pyridin-2-yl)methanone. I found the field of Chemistry very interesting. Saw the article Triazole-based ligands functionalized silica: Effects of ligand denticity and donors on catalytic oxidation activity of Pd nanoparticles published in 2019.0, Reprint Addresses Sangtrirutnugul, P (corresponding author), Mahidol Univ, Ctr Excellence Innovat Chem PERCH CIC, Ctr Catalysis, Dept Chem,Fac Sci, 272 Rama VI Rd, Bangkok 10400, Thailand.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone.

Triazole-based ligands, tris (triazolyl)methanol (Htbtm), bis (triazolyl)-phenylmethanol (Hbtm), and phenyl (pyridin-2-yl)(triazolyl)methanol (Hpytm), with differences in ligand denticity (i.e., bidentate and tridentate) and type of N donors (i.e., triazole and pyridine) were functionalized onto a silica support to produce the corresponding SiO2-L (L = tbtm, btm, pytm). Subsequent reactions with Pd (CH3COO)(2) in CH2Cl2 yielded Pd/SiO2-L. ICP-MS reveals that Pd loadings are higher with increased N loadings, resulting in the following trend: Pd/SiO2-tbtm (0.83 mmol Pd g(-1)) > Pd/SiO2-btm (0.65 mmol Pd g(-1)) ~ Pd/SiO2-pytm (0.63 mmol Pd g(-1)). Meanwhile, TEM images of the used Pd/SiO2-L catalysts after the first catalytic cycle show that the mean size of Pd NPs is highest with Pd/SiO2-pytm (8.5 +/- 1.5 nm), followed by Pd/SiO2-tbtm (6.4 +/- 1.6 nm) and Pd/SiO2-btm (4.8 +/- 1.3 nm). Based on TONs, catalytic studies toward aerobic oxidation of benzyl alcohol to benzaldehyde at 60 degrees C in EtOH showed that Pd/SiO2-pytm possessed the most active surface Pd(0) atoms, most likely as a result of more labile properties of the pyridine-triazole ligand compared to tris- and bis (triazolyl) analogs. ICP-MS and TEM analysis of Pd/SiO2-btm indicate minimal Pd leaching and similar average Pd NPs sizes after 1(st) and 5(th) catalytic runs, respectively, confirming that SiO2-btm is an efficient Pd NPs stabilizer. The Pd/SiO2-btm catalyst was also active toward aerobic oxidation of various benzyl alcohol derivatives in EtOH and could be reused for at least 7 reaction cycles without a significant activity loss.

Quality Control of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Ampawa, S; Krittametaporn, N; Ungpittagul, T; Phomphrai, K; Sangtrirutnugul, P or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

I found the field of Chemistry very interesting. Saw the article Metal-free oxidative C(sp(3))-H functionalization: a facile route to quinoline formaldehydes from methyl-azaheteroarenes published in 2020.0. SDS of cas: 91-02-1, Reprint Addresses Zhu, YP; Sun, YY; Meng, QG (corresponding author), Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Sch Pharm,Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Shandong, Peoples R China.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

A facile protocol for the synthesis of quinoline formaldehydes via direct oxidative C-H bonds functionalization of methyl-azaheteroarenes in the presence of I-2-DMSO has been described. This method is metal-free and easy to operate. This reaction provided a convenient route for the preparation of a range of important quinoline formaldehydes.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Weng, WZ; Guo, JS; Liu, KX; Shao, TQ; Song, LQ; Zhu, YP; Sun, YY; Meng, QG or concate me.. SDS of cas: 91-02-1

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem